advertisement
Liu K 25
Showing records 1 to 25 | Display all abstracts from Liu K80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M
Journal of Glaucoma 2019; 28: 375-385
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Zhang F
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752
80614 Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Feinstein MA
Clinical and Experimental Ophthalmology 2019; 47: 766-773
81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Tang W; Zhang F
Medicine 2019; 98: e16597
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Liu K
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Lu F
Journal of Glaucoma 2019; 28: 375-385
80614 Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Lee JH
Clinical and Experimental Ophthalmology 2019; 47: 766-773
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Cao M
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Kawata H
Journal of Glaucoma 2019; 28: 375-385
81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Liu K
Medicine 2019; 98: e16597
80614 Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Amoozgar B
Clinical and Experimental Ophthalmology 2019; 47: 766-773
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Qu J
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752
81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Duan X
Medicine 2019; 98: e16597
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Iwata A
Journal of Glaucoma 2019; 28: 375-385
80614 Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Liu K
Clinical and Experimental Ophthalmology 2019; 47: 766-773
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Zhou D
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Liu K
Journal of Glaucoma 2019; 28: 375-385
80614 Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Stewart JM
Clinical and Experimental Ophthalmology 2019; 47: 766-773
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Odani-Kawabata N
Journal of Glaucoma 2019; 28: 375-385
80614 Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Lazcano-Gomez G
Clinical and Experimental Ophthalmology 2019; 47: 766-773
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Pan Z
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Shams NK
Journal of Glaucoma 2019; 28: 375-385
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Duan X
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752
80614 Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Porco T; Han Y
Clinical and Experimental Ophthalmology 2019; 47: 766-773
81361 Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Zhou Y
Investigative Ophthalmology and Visual Science 2019; 60: 2743-2752